Nanotechtonics, an emerging discipline integrating nanotechnology principle for controlled material assembly, has revolutionized antimicrobial strategies. This approach enables precise manipulation of nanoscale materials, enhancing their interaction with microbial pathogens. Antimicrobial nanomaterials exhibit multiple mechanisms, including direct physical disruption of microbial membranes, reactive oxygen species (ROS) generation, ion release, and enzyme inhibition. The nanotechnology also helped in devising nanocarriers that allow targeted drug delivery, increasing therapeutic efficiency while minimizing side effects. The major antimicrobial nanomaterials include metallic nanoparticles (silver, copper, zinc oxide), carbon-based nanostructures (fullerenes, graphene, carbon nanotubes), and polymeric nanocomposites (chitosan, PLGA-based systems). These materials exhibit superior antimicrobial efficacy compared to conventional antibiotics due to their multi-targeted mechanisms, diminishing the possibility that resistance will emerge. Despite their advantages, issues such as cytotoxicity, stability, and environmental concerns remain significant obstacles to widespread application. Future advancements in nanotechtonics will focus on developing bio-inspired, eco-friendly nanomaterials with controlled release properties and smart antimicrobial functionalities. Personalized nanomedicine approaches could further enhance treatment specificity, paving the way for next-generation antimicrobial solutions. This interdisciplinary convergence of nanotechnology and microbiology holds immense potential in combating antimicrobial resistance and addressing global health challenges.